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ABSTRACT 
The first step in HIV-1 entry is the interaction between viral envelope glycoprotein gp120 
and CD4 receptor on permissive host cells. The interaction initiates a series of sequential 
conformational rearrangements that exposes epitopes involved in interaction with co-
receptors. Using x-ray crystallography, the tertiary structural rearrangements are elucidated. 
However, the envelope glycoprotein on the virus surface is arranged as a trimer consisting of 
three gp120 and three gp41 subunits (Env) and the tertiary conformational change observed 
in gp120 has not been characterised in the context of a quaternary structure with sufficient 
conformity. 
In this thesis, the envelope glycoprotein responsible for initiating virus entry, Env, was 
studied using cryo-electron microscopy. The quaternary structure of Env, in the pre-entry and 
entry intermediate, provided evidence of conformational shifts upon receptor or ligand-
binding. This method was further used to analyse the quaternary structure of another ligand-
bound Env, the Tat protein-bound Env. The Tat protein-bound Env was studied due to the 
postulation that Tat protein contributes, in part, to disease progression. This stems from the 
observations that combination vaccine trials encompassing both Tat and Env proteins 
protected macaques from mucosal SHIV challenge, that monoclonal anti-Tat antibodies 
inhibited HIV-1 replication and that HIV-1 infected individuals who are slow progressors of 
the disease (have a longer clinical asymptomatic phase) show an inverse relationship in their 
anti-Tat antibody levels and viral load magnitude. In addition, the combined Tat-Env vaccine 
induced antibodies that recognised more regions in Env and had antibodies with higher 
reactivity for epitopes in the V3 loop of Env. 
Comparative analysis of the structures obtained showed that after HIV-1 binding to its 
receptor CD4, the tertiary conformational arrangement of gp120 is translated to the following 
quaternary changes: gp120 subunit tilt from the z-axis, gp120 subunit rotation along its own 
axis and rotation of CD4 epitopes with concomitant exposure of co-receptor epitopes. 
Including the Tat protein-bound Env in the comparison showed that Tat-bound Env has a 
conformation intermediate between the native and CD4-bound Env, and hence, optimal for 
virus entry. This structure change could explain the increased disease progression in patients 
with low anti-Tat antibody to viral load magnitude and slower disease progressions in those 
patients with high anti-Tat antibody. In addition, the intermediate structure of Tat-gp120 
complex could expose epitopes on gp120 that provide better immune protection in slow 
progressors. 
This thesis further evaluated the effect of Tat protein treatment of HIV-1 on infectivity and 
spread in vitro, showing that Tat protein increases infection in target cells and increases 
spread between infected and non-infected cells through cell-cell contacts. The increased 
infectivity and spread was proposed to be due to interaction of Tat protein with the V3 loop 
of gp120, which potentially alters the co-receptor recognition. In this way, HIV-1 of a 
particular tropism, for example an X4-tropic HIV-1, could infect by using CCR5 as a co-
receptor instead. Moreover, the low concentration of circulating Tat protein observed in the 
serum of HIV-1 patients could be a result of regulation by the virus as Tat protein at high 
concentration was found to have a negative impact on infectivity rates. 
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